All In MedTech

Device Trial Radar · NCT03975257

Ectoin Lozenges (EHT02) in the Treatment of Oropharyngeal Allergic Symptoms

Application of Ectoin Lozenges (EHT02) in Patients With Oropharyngeal Allergic Symptoms

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

90

Actual

Start

Feb 4, 2019

Primary completion

Sep 12, 2019

Study completion Sep 12, 2019

Sponsor

Lead sponsor
Bitop AGNot on our public-company list
Sponsor type
Industry
First posted
Jun 5, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this multicentric, prospective, randomised, controlled study (§23b German Act on Medical Devices (MPG)) is to investigate the efficacy of Ectoin Lozenges (EHT02) in treatment and prevention of oropharyngeal allergic symptoms.

Conditions

  • Allergy

Interventions

  • Medical Device: Ectoin LozengeDevice

    Application of Ectoin Lozenge (EHT02) in accordance with the instructions for use

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. cumulative score of allergic symptoms of the lips evaluated by the patientTime frame: about 30 minutes after SLIT-initiation
  2. cumulative score of allergic symptoms of the mouth evaluated by the patientTime frame: about 30 minutes after SLIT-initiation
  3. cumulative score of allergic symptoms of the throat evaluated by the patientTime frame: about 30 minutes after SLIT-initiation

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Facharzt f. HNO-Heilkunde

    Aachen, Germany

  • Fachärztin für Hals-Nasen-Ohrenheilkunde

    Bad Schörnborn, Germany

  • Facharzt f. Dermatologie ruhrDerm GbR

    Bochum, Germany

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.